News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Support Long-Term and Continued Access to GAMMAKED®  18-08-2026 Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Support Long-Term and Continued Access to GAMMAKED®  Read the news
Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026 14-07-2026 Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026 Read the news
Kedrion Launches QIVIGY® in the U.S. with Nationwide Distribution 06-03-2026 Kedrion Launches QIVIGY® in the U.S. with Nationwide Distribution Read the news
YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI 09-10-2025 YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI Read the news
Kedrion Biopharma and CuraScript SD Team Up to Launch YIMMUGO in the U.S.  09-10-2025 Kedrion Biopharma and CuraScript SD Team Up to Launch YIMMUGO in the U.S.  Read the news
Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan to increase investments in the U.S. throughout its global operations 29-09-2025 Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan to increase investments in the U.S. throughout its global operations Read the news
FDA grants Orphan Drug Designation to investigational plasma-derived treatment for Congenital Aceruloplasminemia  07-08-2025 FDA grants Orphan Drug Designation to investigational plasma-derived treatment for Congenital Aceruloplasminemia  Read the news
2025 Annual Report - The Chain of Care
From those who donate, to our work in operations and research, to the experiences of patients, communities, and our people. A year of growth and progress, marked by key milestones and a continued focus on what matters most. Real stories across the Chain. 👉 Explore the Report!
Read more
shield-1
Pharmacovigilance
genetics-1
Medical & Scientific Information